Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
Sales | 9 | 3 | 2 | 421 | 551 |
Gross Profit | 9 | 3 | 2 | 421 | 551 |
Operating Expenses | 28,475 | 18,947 | 12,493 | 5,189 | 27,785 |
Operating Income | -28,466 | -18,944 | -12,491 | -4,768 | -27,234 |
Pre-tax Income | -28,466 | -18,944 | -12,491 | -4,768 | -27,234 |
Net Income Continuous | -28,466 | -18,944 | -12,491 | -4,768 | -27,234 |
Net Income | $-28,466 | $-18,944 | $-12,491 | $-4,768 | $-27,234 |
EPS Basic Total Ops | -1.37 | -1.23 | -1.04 | -0.59 | -6.28 |
EPS Basic Continuous Ops | -1.37 | -1.23 | -1.04 | -0.59 | -6.28 |
EPS Diluted Total Ops | -1.37 | -1.23 | -1.04 | -0.59 | -6.28 |
EPS Diluted Continuous Ops | -1.37 | -1.23 | -1.04 | -0.59 | -6.28 |
EBITDA(a) | $-28,426 | $-18,928 | $-12,376 | $-4,681 | $-27,162 |